Céline Marban

1.1k total citations
22 papers, 803 citations indexed

About

Céline Marban is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Céline Marban has authored 22 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Virology and 7 papers in Infectious Diseases. Recurrent topics in Céline Marban's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and Antimicrobial Peptides and Activities (3 papers). Céline Marban is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and Antimicrobial Peptides and Activities (3 papers). Céline Marban collaborates with scholars based in France, Ireland and United States. Céline Marban's co-authors include Olivier Rohr, Dominique Aunis, Carine Van Lint, Lætitia Redel, Samuel Dequiedt, Stéphane de Walque, Evelyne Schaeffer, Christian Schwartz, Valentin Le Douce and Thomas Cherrier and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.

In The Last Decade

Céline Marban

22 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline Marban France 13 468 374 294 215 81 22 803
Miguel Otero United States 13 250 0.5× 200 0.5× 177 0.6× 198 0.9× 105 1.3× 24 614
Mary Ann Checkley United States 10 435 0.9× 335 0.9× 247 0.8× 201 0.9× 175 2.2× 12 814
Ruonan Zhang China 11 161 0.3× 164 0.4× 99 0.3× 166 0.8× 37 0.5× 26 425
Vaibhav B. Shah United States 13 533 1.1× 294 0.8× 398 1.4× 185 0.9× 133 1.6× 15 791
Tobias Nolden Germany 15 193 0.4× 185 0.5× 107 0.4× 44 0.2× 119 1.5× 29 513
Sarah L. Price United States 8 338 0.7× 118 0.3× 200 0.7× 118 0.5× 94 1.2× 13 547
José L. Affranchino Argentina 16 349 0.7× 223 0.6× 183 0.6× 66 0.3× 366 4.5× 39 747
Martha Stefanidou United States 10 95 0.2× 128 0.3× 78 0.3× 119 0.6× 169 2.1× 10 462
Gengfu Xiao China 16 38 0.1× 323 0.9× 220 0.7× 95 0.4× 143 1.8× 35 712
R. Presentini Italy 13 67 0.1× 278 0.7× 62 0.2× 250 1.2× 45 0.6× 28 661

Countries citing papers authored by Céline Marban

Since Specialization
Citations

This map shows the geographic impact of Céline Marban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Marban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Marban more than expected).

Fields of papers citing papers by Céline Marban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Marban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Marban. The network helps show where Céline Marban may publish in the future.

Co-authorship network of co-authors of Céline Marban

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Marban. A scholar is included among the top collaborators of Céline Marban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Marban. Céline Marban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collinge, Mark, Patricia Schneider, Dingzhou Li, et al.. (2020). Cross-company evaluation of the human lymphocyte activation assay. Journal of Immunotoxicology. 17(1). 51–58. 4 indexed citations
2.
Haïkel, Youssef, et al.. (2019). Correction to: A New Combination with D-Cateslytin to Eradicate Root Canal Pathogens. International Journal of Peptide Research and Therapeutics. 25(4). 1689–1689. 1 indexed citations
3.
Haïkel, Youssef, et al.. (2019). A New Combination with D-Cateslytin to Eradicate Root Canal Pathogens. International Journal of Peptide Research and Therapeutics. 25(4). 1679–1687. 2 indexed citations
4.
Boehler, Christian, Morgane Rabineau, Jean‐Marc Strub, et al.. (2018). D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections. Scientific Reports. 8(1). 9235–9235. 21 indexed citations
5.
Schwartz, Christian, Sophie Bouchat, Céline Marban, et al.. (2017). On the way to find a cure: Purging latent HIV-1 reservoirs. Biochemical Pharmacology. 146. 10–22. 41 indexed citations
6.
Daouad, Fadoua, Fabienne Quilès, Grégory Francius, et al.. (2017). D-Cateslytin, a new antimicrobial peptide with therapeutic potential. Scientific Reports. 7(1). 15199–15199. 33 indexed citations
7.
Douce, Valentin Le, Sebastian Eilebrecht, Benoît Van Driessche, et al.. (2016). HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1. Scientific Reports. 6(1). 34920–34920. 21 indexed citations
8.
Douce, Valentin Le, Amina Aït-Ammar, Fadoua Daouad, et al.. (2016). Improving combination antiretroviral therapy by targeting HIV-1 gene transcription. Expert Opinion on Therapeutic Targets. 20(11). 1311–1324. 13 indexed citations
9.
Pasqua, Teresa, Anna Maria Quintieri, Francesco Scavello, et al.. (2015). Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury. Peptides. 71. 40–48. 21 indexed citations
10.
Aslam, Rizwan, Céline Marban, F. Jehl, et al.. (2013). Cateslytin, a Chromogranin A Derived Peptide Is Active against Staphylococcus aureus and Resistant to Degradation by Its Proteases. PLoS ONE. 8(7). e68993–e68993. 20 indexed citations
11.
Aslam, Rizwan, Benoît‐Joseph Laventie, Céline Marban, et al.. (2013). Activation of Neutrophils by the Two-Component Leukotoxin LukE/D from Staphylococcus aureus: Proteomic Analysis of the Secretions. Journal of Proteome Research. 12(8). 3667–3678. 4 indexed citations
12.
13.
Marban, Céline, et al.. (2012). Interplay between the HTLV-2 Tax and APH-2 proteins in the regulation of the AP-1 pathway. Retrovirology. 9(1). 98–98. 16 indexed citations
14.
Marban, Céline, William W. Hall, & Noreen Sheehy. (2011). Regulation of AP-1 activity by the HTLV-2 APH-2 protein. Retrovirology. 8(S1). 1 indexed citations
15.
Schwartz, Christian, Valentin Le Douce, Thomas Cherrier, et al.. (2010). Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. médecine/sciences. 26(2). 159–164. 6 indexed citations
16.
Cherrier, Thomas, Valentin Le Douce, Lætitia Redel, et al.. (2010). Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. médecine/sciences. 26(3). 291–296. 6 indexed citations
17.
Cherrier, Thomas, Lætitia Redel, Miriam Calao, et al.. (2009). p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene. 28(38). 3380–3389. 95 indexed citations
18.
Marban, Céline, Samuel Dequiedt, Stéphane de Walque, et al.. (2007). Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing. The EMBO Journal. 26(2). 412–423. 289 indexed citations
19.
Goumon, Yannick, Elise Glattard, Céline Marban, et al.. (2006). Identification of Morphine-6-glucuronide in Chromaffin Cell Secretory Granules. Journal of Biological Chemistry. 281(12). 8082–8089. 30 indexed citations
20.
Rohr, Olivier, Céline Marban, Dominique Aunis, & Evelyne Schaeffer. (2003). Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. Journal of Leukocyte Biology. 74(5). 736–749. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Otero Breakdown of academic impact, for papers by Mary Ann Checkley Breakdown of academic impact, for papers by Ruonan Zhang Breakdown of academic impact, for papers by Vaibhav B. Shah Breakdown of academic impact, for papers by Tobias Nolden Breakdown of academic impact, for papers by Sarah L. Price Breakdown of academic impact, for papers by José L. Affranchino Breakdown of academic impact, for papers by Martha Stefanidou Breakdown of academic impact, for papers by Gengfu Xiao Breakdown of academic impact, for papers by R. Presentini
Rankless by CCL
2026